Las Vegas, NV -- (SBWIRE) -- 12/12/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is On: Synthetic Biologics Inc(NYSEMKT:SYN), Himax Technologies, Inc. (ADR)(NASDAQ:HIMX), Opko Health Inc.(NYSE:OPK), Constellium NV(NYSE:CSTM)
Synthetic Biologics Inc(NYSEMKT:SYN) was trading lower at -22.05% to 0.990.So far, around 3.10 million shares have changed hands in this session. After opening at $1.02, the stock hit as high as $1.03. However, it traded between $0.95 and$2.10 over the last twelve months. Synthetics Biologics, Inc., a biotechnology company, focuses on the development of biologics for the prevention and treatment of serious infectious diseases.
Has SYN Found The Bottom and Ready To Move Up? Find Out Here
Himax Technologies, Inc. (ADR)(NASDAQ:HIMX) was at $10.94, showing a -1.75% decrease. Around 3.04 million shares have been traded, versus an-average trading volume of 6.75M shares. The company is now valued at around $1.86 billion. Himax Technologies, Inc. designs, develops, and markets semiconductors for flat panel displays.
Has HIMX Found The Bottom And Ready To Gain Momentum? Find Out Here
Opko Health Inc.(NYSE:OPK) moved -1.83 per cent lower at $9.63 and is trading between $9.62 and $10.15 after opening the day at $10.10. Its performance over the last five days remained -8.63%, which stands at -5.31% for a month. Going back further than one month, 1-year performance after recent close was +100.21%. Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics.
Why Should Investors Buy OPK After the Recent Fall? Just Go Here and Find Out
Constellium NV(NYSE:CSTM)’s shares rose today, gaining +1.19 per cent to $21.32. The stock is up around +46.52% in 2013 and +46.52% for the last 12 months. Around 2.39 million shares changed hands so far in this session compared to an-average trading volume of 530,667.00 shares. Constellium Holdco B.V. engages in the design, manufacture, and sale of specialty rolled and extruded aluminum products.
Why Should Investors Buy CSTM After The Recent Gain? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)